Peptides for Longevity
Anonymous accounts from people taking peptides for longevity — Epitalon, NAD+, humanin, MOTS-c, and SS-31. What they're tracking and what's changed.
11 anonymous reports
community guides:
Community Q&A
- Which peptides are used for longevity?
- Community accounts in the longevity space cluster around: epitalon (pineal bioregulator, typically cycled annually), thymosin alpha-1 (immune support), MOTS-c (mitochondrial function), SS-31 (mitochondrial targeting), and NAD+ precursors. Humanin appears in accounts from users focused on cognitive and metabolic aging markers. BPC-157 and TB-500 are used in longevity contexts for tissue maintenance during long training careers. The bioregulator class (epithalon, pinealon) is distinctly popular among users following Russian longevity protocols.
- What peptides give you more energy?
- The most frequently cited energy-boosting effects in community accounts: MOTS-c (described as clean mitochondrial energy, most commonly pre-workout), CJC-1295 + ipamorelin (improved sleep quality translating to daytime energy), and NAD+ supplementation. Epitalon accounts frequently cite improved sleep architecture and daytime energy as secondary benefits. Semax and selank appear in cognitive-energy accounts focused on mental clarity and reduced fatigue rather than physical output.
- How do people cycle peptides for longevity?
- Cycling patterns in longevity-focused accounts are distinct from performance-focused protocols. Epitalon is almost universally described as an annual cycle — 10–20 day courses once or twice a year, following Russian bioregulator research protocols. Thymosin alpha-1 accounts describe 4–6 week cycles, sometimes tied to cold and flu season or periods of high stress. MOTS-c accounts are split between daily use at low doses and 3-days-on, 4-days-off patterns. The rationale for cycling in accounts: avoiding receptor desensitisation and staying consistent with the protocols that produced the underlying research — most longevity-focused users are more conservative about deviation from studied protocols than performance-focused users.
- Which longevity peptides have the most community evidence behind them?
- By volume of accounts in the archive, epitalon leads — it has the most consistent longevity-specific user base and the clearest protocol consensus (annual cycles, sleep and energy as primary reported benefits). Thymosin alpha-1 is second, with accounts clustering around immune resilience and cancer adjunct use. BPC-157 appears in longevity contexts as a tissue maintenance compound for active users — less about lifespan extension, more about maintaining function across decades of training. MOTS-c is newer in the community and has fewer accounts, but those that exist are unusually specific about outcomes — metabolic markers, fasting glucose, exercise capacity. SS-31 and humanin are present but remain niche; accounts tend to come from users with a stronger research background than typical community members.